Zenas BioPharmaZBIO
那斯達克 · USD
15.41
-0.30
(-1.91%)
收盤 08/02 03:58 (UTC+8)
盤後
0
0
(0%)
08/02 03:58 (UTC+8)
Zenas BioPharmaZBIO
15.41
-0.30
(-1.91%)
財務數據
損益表
- -
- 0.00
- 0.50
- 0.00
- 0.00
- 0.00
- -
- 0.05
- 0.10
- -
- -
- -
- -
- -
- -
- -
- -
- 100.00
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2022/Q4 | |
營業收入淨額 | 10,000 | 5,000 | - | 0 | 0 | 0 | 50,000 | 0 | - |
營業成本 | - | - | - | - | - | - | - | - | - |
營業毛利 | 10,000 | 5,000 | - | 0 | 0 | 0 | 50,000 | 0 | - |
營業費用 | 47,330 | 60,623 | 40,985 | 39,702 | 27,578 | 24,779 | 14,376 | 18,905 | 76,199 |
研發費用 | 34,915 | 49,157 | 33,530 | 33,807 | 22,645 | 20,418 | 9,352 | 14,915 | 61,689 |
推銷及管理費用 | 12,415 | 11,466 | 7,455 | 5,895 | 4,933 | 4,361 | 5,024 | 3,990 | 13,510 |
非經常性項目費用 | - | - | - | - | - | - | - | - | 1,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - |
營業利益 | -37,330 | -55,623 | -40,985 | -39,702 | -27,578 | -24,779 | 35,624 | -18,905 | -76,199 |
其他收入及費用 | 3,552 | 3,448 | 2,378 | - | - | - | - | - | -43,144 |
利息費用 | - | - | - | - | - | - | - | - | - |
稅前純益 | -33,778 | -52,175 | -104,384 | -37,977 | -27,800 | -24,286 | 35,608 | -29,047 | -119,282 |
所得稅 | -205 | 429 | - | - | 0 | - | - | - | - |
稅後純益 | -33,573 | -52,604 | -104,384 | -37,977 | -27,800 | -24,587 | 35,608 | -29,047 | -119,282 |
基本每股稅後盈餘(元) | -0.80 | - | -5.02 | - | -0.70 | - | 0.21 | - | - |
稀釋每股稅後盈餘(元) | -0.80 | 16.94 | 13.32 | - | -0.70 | - | 0.21 | - | - |
基本平均股數(千股) | 41800.00 | - | 7697.00 | - | 39792.00 | - | 17415.00 | - | - |
稀釋平均股數(千股) | 41800.00 | - | 7697.00 | - | 39792.00 | - | 17415.00 | - | - |
還原基本每股稅後盈餘(元) | -0.80 | - | -5.02 | - | -0.70 | - | 0.21 | - | - |
還原稀釋每股稅後盈餘(元) | -0.80 | 16.94 | 13.32 | - | -0.70 | - | 0.21 | - | - |
還原基本平均股數(千股) | 41,800 | - | 7,697 | - | 39,792 | - | 17,415 | - | - |
還原稀釋平均股數(千股) | 41,800 | - | 7,697 | - | 39,792 | - | 17,415 | - | - |
EBITDA(千元) | -34,137 | -52,744 | -104,348 | -37,942 | -27,767 | -24,557 | 35,634 | -29,018 | -119,204 |